- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02348645
Decompression vs. Fusion for Stable Degenerative Spondylolisthesis
Decompression Alone vs. Decompression and Instrumented Fusion for the Management of Lumbar Spinal Stenosis Associated With Stable Degenerative Spondylolisthesis: A Pragmatic Randomized Clinical Pilot Trial
The purpose of this study is to assess the feasibility of a full-scale multicenter randomized, controlled trial comparing the effectiveness of two surgical treatments for a condition associated with lumbar spinal stenosis called degenerative lumbar spondylolisthesis. Both treatments are currently used, but individual surgeons use different selection criteria for each treatment and use the procedures at different rates. The two procedures are decompression with fusion (the most common surgical procedure for spondylolisthesis) and midline-sparing decompression alone (which is also a standard treatment, but is not as widely used for treating spondylolisthesis). The investigators plan to collect the evidence on the following:
- The feasibility of the trial protocol, and
- Preliminary data on the effectiveness of each treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2N9
- Foothills Medical Centre
-
Edmonton, Alberta, Canada, T6G 2B7
- Mackenzie Health Sciences Centre
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 1M9
- Vancouver General Hospital
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Queen Elizabeth II Health Sciences Centre
-
-
Ontario
-
London, Ontario, Canada, N6A 5W9
- London Health Sciences Centre - Victoria Hospital
-
Toronto, Ontario, Canada, M4N 3M5
- Sunnybrook Health Sciences Centre
-
Toronto, Ontario, Canada, M5T 2S8
- University Health Network
-
-
Quebec
-
Montreal, Quebec, Canada, H3G 1A4
- Montreal General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients deemed to be surgical candidates with focal (1-2 level) lumbar spinal stenosis (LSS) and associated stable degenerative spondylolisthesis with the following characteristics:
- a clinical history of back, buttock and leg pain with walking or standing that is improved when lying, sitting or bending forward
- a clinical history of leg symptoms that are greater than or equal to back symptoms with walking or standing, and
- greater than 6 months of symptoms with failed conservative care
- aged 50 or over
- sufficient fluency in English or French to provide informed consent and complete questionnaires with or without the need of an interpreter
Exclusion Criteria:
- Greater than 25% listhesis or spinal instability as demonstrated by motion (>5mm of translation) on flexion extension radiographs or non-loaded (MRI/CT or supine x-rays) to loaded imaging (standing radiograph)
- Presence of kyphosis (>0 degrees at the affected level or globally), degenerative scoliosis (>10 degree using the Cobb method) with rotatory or lateral listhesis on preoperative x-rays
- Clinical history of osteoporotic fracture or chronic oral steroid use
- Previous posterior lumbar spinal surgery (excluding prior microdiscectomy)
- Patients who have evidence of neurological disorders that affect physical function (e.g. peripheral neuropathy), neuromuscular disorders (e.g. multiple sclerosis, Parkinson's etc.) or systemic illness (e.g. inflammatory arthritis) that affects physical function
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Decompression with fusion
Spinal decompression surgery with instrumented spinal fusion
|
|
|
Active Comparator: Decompression alone
Midline-sparing spinal decompression alone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients recruited
Time Frame: 1 year
|
1 year
|
|
|
Number of eligible patients
Time Frame: 1 year
|
1 year
|
|
|
Reasons for refusal to consent
Time Frame: 1 year
|
1 year
|
|
|
Proportion of patients who adhere to randomized allocation
Time Frame: 2 years
|
2 years
|
|
|
Number of patients refusing to consent due to blinding
Time Frame: 1 year
|
1 year
|
|
|
Blinding status
Time Frame: 1.5 months post-surgery
|
Patient's assessment of which treatment they received
|
1.5 months post-surgery
|
|
Oswestry Disability Index (ODI)
Time Frame: 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
|
10-item patient-reported questionnaire measuring disability related to low back pain.
Each item has six response options ranging from 0 to 5; the responses are summed and rescaled so 0 indicates no disability and 100 indicates extreme disability.
|
6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
|
|
Proportion of patients who receive randomized allocation
Time Frame: 2 years
|
2 years
|
|
|
Number of patients refusing to consent due to randomization
Time Frame: 1 year
|
1 year
|
|
|
Number, type and severity of adverse events
Time Frame: End of hospital stay (average 6.5 days post-surgery)
|
End of hospital stay (average 6.5 days post-surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short-Form 12 scores: Physical Function, Bodily Pain, Physical Component Summary
Time Frame: Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
|
12-item patient-reported questionnaire for general health status based on the SF-36 Health Survey (version 2).
Measures eight health domains, each scored so 0 is the worst and 100 is the best possible score: general health (GH), physical function (PF), bodily pain (BP), role limitations due to physical problems (RP), role limitations due to emotional problems (RE), mental health (MH), social functioning (SF), and energy/fatigue (VT).
The domain scores can be aggregated into Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, also scaled so 0 is the worst and 100 is the best possible score.
This study will focus primarily on the Physical Function domain, the Bodily Pain domain, and the Physical Component Summary score.
|
Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
|
|
Euro-QoL health utility index
Time Frame: Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
|
Patient-reported questionnaire for general health state which includes five items (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a visual analog scale for self-rated health state.
Using an existing U.S. population-based value set, responses will be converted to the corresponding health utility index (1.0=perfect
health and 0.0=death).
|
Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
|
|
Patient Health Questionnaire-9 score
Time Frame: Baseline
|
Patient-reported questionnaire that measures severity of depression symptoms.
It is scored from 0 to 27, with the following interpretation: 0-4=no symptoms, 5-9=minimal symptoms; 10-14=mild/minor depression or dysthymia; 15-19=moderate major depression; 20-27=severe major depression.
|
Baseline
|
|
Costs incurred by patients
Time Frame: monthly from 1.5 to 12 months post-surgery; 24 months post-surgery
|
monthly from 1.5 to 12 months post-surgery; 24 months post-surgery
|
|
|
Hospital cost
Time Frame: End of hospital stay (average 6.5 days post-surgery)
|
End of hospital stay (average 6.5 days post-surgery)
|
|
|
Healthcare services used
Time Frame: Referral to 1 year post-surgery
|
Other Ontario Health Insurance Plan (OHIP)-billed services used
|
Referral to 1 year post-surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yoga Raja Rampersaud, MD FRCSC, University Health Network, Toronto
- Principal Investigator: Anthony Perruccio, PhD, University Health Network, Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Bone Diseases
- Musculoskeletal Diseases
- Spinal Diseases
- Back Pain
- Spondylolysis
- Spondylosis
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Spinal Stenosis
- Low Back Pain
- Spondylolisthesis
- Therapeutics
- Surgical Procedures, Operative
- Neurosurgical Procedures
- Orthopedic Procedures
- Decompression, Surgical
- Arthrodesis
- Laminectomy
- Spinal Fusion
Other Study ID Numbers
- 13-6927
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Stenosis
-
Azienda Usl di BolognaCompletedLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
RTI SurgicalCompletedSpinal Disease | Spinal Instability | Spinal Stenosis Occipito-Atlanto-Axial | Spinal Stenosis Cervical | Spinal Stenosis Cervicothoracic RegionUnited States
-
The First Affiliated Hospital with Nanjing Medical...Xuzhou Central Hospital; The First People's Hospital of LianyungangNot yet recruiting
-
Punjab Health Care CommissionRecruitingLumbar Spinal StenosisPakistan
-
Universidad Complutense de MadridHospital San Carlos, Madrid; FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO...RecruitingLumbar Spinal Stenosis | Lumbar Spinal Stenosis (LSS) | Lumbar Canal StenosisSpain
-
Ain Shams UniversityGeneral Organization for Teaching Hospitals and InstitutesCompletedLumbar Spinal StenosisEgypt
-
Hatice Çetintürk ŞahinCompletedLumbar Spinal StenosisTurkey (Türkiye)
-
Sutherland Medical CenterActive, not recruitingSpinal Stenosis Lumbar | Spinal Canal StenosisPoland
-
Massachusetts General HospitalCompletedLumbar Spinal Stenosis | Thoracic Spinal StenosisUnited States
Clinical Trials on Spinal fusion
-
Olympus Biotech CorporationCompleted
-
Stryker SpineNot yet recruitingDegenerative Disc Disease | Degenerative Scoliosis
-
Istituto Ortopedico RizzoliCompletedSurgery--Complications | Spinal Fusion | Spine DiseaseItaly
-
Mohammad ARAB MOTLAGHCompleted
-
University of Colorado, DenverCompletedScoliosisUnited States
-
Flexuspine, Inc.Completed
-
University of PittsburghWithdrawnSpinal Stenosis | Degenerative Spondylolisthesis
-
Mesoblast, Ltd.CompletedDegenerative Disc Disease | Spinal Stenosis | SpondylolisthesisUnited States
-
Rigshospitalet, DenmarkFrederiksberg University HospitalCompleted
-
Bergman ClinicsMICN Lab, University Hospital ZurichCompletedLow Back Pain | Disk Herniated Lumbar | Spinal Stenosis LumbarFrance, Austria, Netherlands